STOK
STOK
NASDAQ · Biotechnology

Stoke Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$33.08
+0.36 (+1.10%)
As of May 9, 1:31 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +51.7% upside
Low Target $29.72
Average Target $50.17
High Target $68.67
Current Price $33.08
Current
$33.08
Target
$50.17
$29.72 $50.17 avg $68.67
Scenario Analysis
Bear Case
$29.72
-10.2%
Low target
Base Case
$50.17
+51.7%
Avg target
Bull Case
$68.67
+107.6%
High target
Risk/Reward
10.6x
Highly favorable
Price in Context
52-Week High
$40.22
-17.8% from high
52-Week Low
$8.51
+288.7% from low
Target vs 52W High
$50.17
+24.7% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.84
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%